Congress

ESMO 2024

European Society for Medical Oncology

Join us at the ESMO Congress 2024

BeiGene will be at the annual ESMO Congress in Barcelona. ESMO 2024 presents an exciting opportunity for clinicians from around the world to discuss cutting-edge data and expand their knowledge with high-quality education sessions, as well as engage in meaningful conversations with patient advocates, healthcare industry representatives, and other stakeholders.

We hope to see you in person in Barcelona. Come and find us at booth 309.

Please join our BeiGene-sponsored Satellite Symposium: A new comprehensive approach to lung cancer treatment

The BeiGene-sponsored Satellite Symposium will be held on September 16th, 13.00-14.30 in Toledo Auditorium, Hall 3. Add this Satellite Symposium to your calendar!

This symposium, co-chaired by Prof. Silvia Novello and Prof. Tony Mok, will provide an overview of tislelizumab data in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Audience participation is encouraged, with panel discussions and audience Q&A throughout the session. Dr. Mariano Provencio will present data from the pivotal trial in resectable NSCLC (neo-adjuvant/adjuvant). Prof. Mok and Prof. Martin Reck will debate whether single agent immuno-oncology (IO) is the only treatment option for NSCLC with high programmed death-ligand 1 (PD-L1) expression, or whether combination regimens are a suitable alternative. Prof. Luis Paz-Ares will discuss treatment options in NSCLC with low PD-L1 expression. Finally, Prof. Novello will present data from the pivotal trial in first-line (1L) SCLC. Following the presentations, there will be a general panel discussion and an opportunity for the audience to ask the faculty questions.

Webcasts of the Satellite Symposia

After the congress you will find the webcast of the Satellite Symposium in the Congress Resources section of our website.